Ирландия - английский - HPRA (Health Products Regulatory Authority)

baxalta innovations gmbh - human plasma protein >95% immunoglobulins - solution for injection - 160 gram(s)/litre - immunoglobulins, normal human; immunoglobulins, normal human, for extravascular adm. - immune sera and immunoglobulins: immunoglobulins, normal human, for extravascular administration - replacement therapy in adults and children in primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - igg subclass deficiencies with recurrent infections

Европейский союз - английский - EMA (European Medicines Agency)

novo nordisk a/s - human insulin - diabetes mellitus - drugs used in diabetes - treatment of diabetes mellitus.

Европейский союз - английский - EMA (European Medicines Agency)

glaxosmithkline biologicals s.a. - human papillomavirus1 type 16 l1 protein, human papillomavirus type 18 l1 protein - papillomavirus infections; uterine cervical dysplasia; immunization - vaccines - cervarix is a vaccine for use from the age of 9 years for the prevention of premalignant ano-genital lesions (cervical, vulvar, vaginal and anal) and cervical and anal cancers causally related to certain oncogenic human papillomavirus (hpv) types. see sections 4.4 and 5.1 for important information on the data that support this indication.the use of cervarix should be in accordance with official recommendations.

Европейский союз - английский - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - human papillomavirus type 6 l1 protein, human papillomavirus type 11 l1 protein, human papillomavirus type 16 l1 protein, human papillomavirus type 18 l1 protein - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - vaccines - gardasil is a vaccine for use from the age of 9 years for the prevention of:premalignant genital lesions (cervical, vulvar and vaginal), premalignant anal lesions, cervical cancers and anal cancers causally related to certain oncogenic human papillomavirus (hpv) types;genital warts (condyloma acuminata) causally related to specific hpv types.see sections 4.4 and 5.1 for important information on the data that support this indication.the use of gardasil should be in accordance with official recommendations.

Европейский союз - английский - EMA (European Medicines Agency)

cangene europe limited - human hepatitis b immunoglobulin - immunization, passive; hepatitis b - specific immunoglobulins - immunoprophylaxis of hepatitis b - in case of accidental exposure in non-immunised subjects (including persons whose vaccination isincomplete or status unknown).- in haemodialysed patients, until vaccination has become effective.- in the newborn of a hepatitis b virus carrier-mother.- in subjects who did not show an immune response (no measurable hepatitis b antibodies) after vaccination and for whom a continuous prevention is necessary due to the continuous risk of being infected with hepatitis b.consideration should also be given to other official guidance on the appropriate use of human hepatitis b immunoglobulin for intramuscular use.

Европейский союз - английский - EMA (European Medicines Agency)

merck sharp dohme ltd - human papillomavirus type 6 l1 protein, human papillomavirus type 11 l1 protein, human papillomavirus type 16 l1 protein, human papillomavirus type 18 l1 protein - papillomavirus infections; uterine cervical dysplasia; condylomata acuminata; immunization - vaccines - silgard is a vaccine for use from the age of 9 years for the prevention of:premalignant genital lesions (cervical, vulvar and vaginal), premalignant anal lesions, cervical cancers and anal cancers causally related to certain oncogenic human papillomavirus (hpv) types;genital warts (condyloma acuminata) causally related to specific hpv types.see sections 4.4 and 5.1 for important information on the data that support this indication.the use of silgard should be in accordance with official recommendations.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

glimlife australia pty ltd - glycerol, quantity: 151 mg; d-alpha-tocopherol, quantity: 10 mg; lecithin, quantity: 1 mg; curcuma longa, quantity: 200 mg (equivalent: curcuma longa, qty 2 g); glucosamine sulfate sodium chloride, quantity: 75 mg; shark cartilage, quantity: 120 mg; angelica polymorpha, quantity: 2 mg (equivalent: angelica polymorpha, qty 10 mg); dimethyl sulfone, quantity: 80 mg; soya oil, quantity: 660 mg; deer blood, quantity: 90 mg; deer velvet antler powder, quantity: 10 mg - capsule, soft - excipient ingredients: gelatin; purified water; titanium dioxide; yellow beeswax; brilliant blue fcf; sunset yellow fcf - -relieve inflammation. -relieve joint pain associated with mild osteoarthritis. -increase joint mobility and reduce joint stiffness associated with mild osteoarthritis. -may protect joint cartilage in osteoarthritis. -shark cartilage (chondroitin sulfate) helps lubricate and nourish joints. -maintain general wellbeing.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

pro ma systems aust pty ltd - fucus vesiculosus, quantity: 20 mg (equivalent: iodine, qty 100 microgram); natural fish oil, quantity: 166.67 mg (equivalent: docosahexaenoic acid, qty 20 mg; equivalent: eicosapentaenoic acid, qty 30 mg); ascorbic acid, quantity: 60 mg; hesperidin, quantity: 60 mg; glucosamine hydrochloride, quantity: 602.4 mg (equivalent: glucosamine, qty 500 mg); shark sodium chondroitin sulfate, quantity: 83.34 mg; uncaria tomentosa, quantity: 25 mg (equivalent: uncaria tomentosa, qty 100 mg) - capsule, soft - excipient ingredients: yellow beeswax; lecithin; purified water; glycerol; hydrogenated vegetable oil; titanium dioxide; soya oil; gelatin; whey protein; chlorophyllin-copper complex; dibasic sodium phosphate - antioxidant/reduce free radicals formed in the body ; aids/assists natural body cleansing/detoxification processes ; relieve feelings of general malaise/general debility ; enhance/promote/physical endurance/capacity/stamina ; helps enhance/promote/increase vitality ; maintain/support vitality ; helps enhance/promote general health and wellbeing ; maintain/support general health and wellbeing ; anti-inflammatory/relieve inflammation ; analgesic/anodyne/relieve pain ; maintain/support connective tissue health ; helps enhance/promote connective tissue health ; aid/assist/helps connective tissue production/formation ; helps enhance/promote body tissue repair/regeneration ; decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve mild rheumatic aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/supports healthy joint cartilage growth/development/production ; helps enhance/promote healthy joint function ; helps enhance/promote joint health ; maintain/support joint health ; decrease/reduce/relieve mild joint inflammation/swelling ; maintain/support joint mobility/flexibility ; decrease/reduce/relieve mild joint pain/soreness ; decrease/reduce/relieve mild joint stiffness ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; helps prevent dietary (state vitamin/mineral/nutrient) deficiency ; maintain/support (state vitamin/mineral) within normal range

Австралия - английский - Department of Health (Therapeutic Goods Administration)

axpo pty ltd - curcuma longa, quantity: 75 mg (equivalent: curcuma longa, qty 1.5 g; equivalent: curcuminoids (of curcuma longa), qty 48.75 mg); glucosamine sulfate sodium chloride, quantity: 356.25 mg (equivalent: glucosamine sulfate, qty 283.65 mg); nigella sativa, quantity: 300 mg - capsule, hard - excipient ingredients: povidone; colloidal anhydrous silica; maltodextrin; magnesium stearate; microcrystalline cellulose; hypromellose; potable water; potassium acetate; edetic acid; gellan gum - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; anti-inflammatory/relieve inflammation ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps enhance/promote healthy joint function ; maintain/support joint health ; maintain/support joint mobility/flexibility ; decrease/reduce/relieve mild joint pain/soreness ; maintain/support general mental wellbeing

Австралия - английский - Department of Health (Therapeutic Goods Administration)

life biotech pty ltd - nicotinamide, quantity: 25 mg; nicotinic acid, quantity: 15 mg; curcuma longa, quantity: 75 mg (equivalent: curcuma longa, qty 750 mg); glucosamine sulfate potassium chloride, quantity: 995.09 mg (equivalent: glucosamine sulfate, qty 750 mg; equivalent: potassium chloride, qty 245.09 mg; equivalent: potassium, qty 128.31 mg); manganese gluconate, quantity: 13.16 mg (equivalent: manganese, qty 1.5 mg); borax, quantity: 26.55 mg (equivalent: boron, qty 3 mg); dimethyl sulfone, quantity: 250 mg; piper nigrum, - tablet, film coated - excipient ingredients: povidone; maltodextrin; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; magnesium stearate; croscarmellose sodium; hypromellose; macrogol 400; titanium dioxide; iron oxide yellow; carnauba wax - antioxidant/reduce free radicals formed in the body ; maintain/support energy levels ; maintain/support general health and wellbeing ; traditionally used in western herbal medicine to anti-inflammatory/relieve inflammation ; traditionally used in chinese medicine to anti-inflammatory/relieve inflammation ; maintain/support bone health ; aids/assists healthy bone development/growth/building ; maintain/support bone mass/density/integrity ; help maintain/support bone mineralisation ; traditionally used in chinese medicine to decrease/reduce/relieve mild joint aches and pains ; decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; helps maintain/supports healthy joint cartilage growth/development/production ; maintain/support joint health ; maintain/support joint mobility/flexibility ; traditionally used in chinese medicine to decrease/reduce/relieve mild joint pain/soreness